CH622771A5 - - Google Patents

Download PDF

Info

Publication number
CH622771A5
CH622771A5 CH815577A CH815577A CH622771A5 CH 622771 A5 CH622771 A5 CH 622771A5 CH 815577 A CH815577 A CH 815577A CH 815577 A CH815577 A CH 815577A CH 622771 A5 CH622771 A5 CH 622771A5
Authority
CH
Switzerland
Prior art keywords
formula
ethyl
radical
propyl
hydrogen atom
Prior art date
Application number
CH815577A
Other languages
English (en)
French (fr)
Inventor
Lucien Dr Ing Nedelec
Daniel Frechet
Claude Dr Dumont
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of CH622771A5 publication Critical patent/CH622771A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/52—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
CH815577A 1976-07-01 1977-07-01 CH622771A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7620140A FR2356417A1 (fr) 1976-07-01 1976-07-01 Nouveaux derives de monohydroxyphenethylamines et leurs sels, procede de preparation et application a titre de medicaments de ces nouveaux produits

Publications (1)

Publication Number Publication Date
CH622771A5 true CH622771A5 (de) 1981-04-30

Family

ID=9175124

Family Applications (1)

Application Number Title Priority Date Filing Date
CH815577A CH622771A5 (de) 1976-07-01 1977-07-01

Country Status (17)

Country Link
US (1) US4130658A (de)
JP (1) JPS535131A (de)
AT (1) AT350525B (de)
AU (1) AU510829B2 (de)
BE (1) BE856318A (de)
CA (1) CA1039301A (de)
CH (1) CH622771A5 (de)
DE (1) DE2729165C2 (de)
DK (1) DK292377A (de)
ES (1) ES460218A1 (de)
FR (1) FR2356417A1 (de)
GB (1) GB1539133A (de)
IE (1) IE45110B1 (de)
LU (1) LU77661A1 (de)
NL (1) NL7707262A (de)
SE (1) SE7706201L (de)
ZA (1) ZA773683B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2436773A1 (fr) * 1978-09-22 1980-04-18 Roussel Uclaf Nouveaux derives du 3-(aminoethyl) phenol et leurs sels, procede de preparation et application a titre de medicaments
JPS6241829Y2 (de) * 1980-03-28 1987-10-26
FR2646347B1 (fr) * 1989-04-28 1991-08-23 Roussel Uclaf Nouveau derive d'hydroxyphenethylamine et ses sels, procede de preparation, application a titre de medicaments et utilisation comme outil pharmacologique specifique
GB9017390D0 (en) * 1990-08-08 1990-09-19 Norgine Ltd Improvements in or relating to propylamine derivatives
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
EP3277659A1 (de) * 2015-03-30 2018-02-07 University of Innsbruck Diphenethylaminderivate, die unter anderem als analgetika verwendbar sind, und verfahren zu deren herstellung

Also Published As

Publication number Publication date
FR2356417A1 (fr) 1978-01-27
DE2729165C2 (de) 1982-06-09
GB1539133A (en) 1979-01-24
ZA773683B (en) 1978-07-26
LU77661A1 (de) 1978-02-02
IE45110L (en) 1978-01-01
AU510829B2 (en) 1980-07-17
IE45110B1 (en) 1982-06-16
JPS535131A (en) 1978-01-18
SE7706201L (sv) 1978-01-02
DE2729165A1 (de) 1978-01-12
CA1039301A (en) 1978-09-26
ES460218A1 (es) 1978-04-01
US4130658A (en) 1978-12-19
AT350525B (de) 1979-06-11
DK292377A (da) 1978-01-02
BE856318A (fr) 1977-12-30
NL7707262A (nl) 1978-01-03
AU2661477A (en) 1979-01-04
FR2356417B1 (de) 1978-12-15
ATA458877A (de) 1978-11-15

Similar Documents

Publication Publication Date Title
CA1116635A (fr) Procede de preparation de nouveaux derives de la benzene propanamine et de leurs sels
CA1193247A (fr) Procede de preparation de nouveaux derives du 3-amino- pregn-5ene et de leurs sels
CH628344A5 (fr) Procede de preparation de nouveaux derives du piperidyl-indole et de leurs sels.
FR2526659A1 (fr) Medicaments immunomodulants a base de derives de l'acide phenylacetique
CH617923A5 (de)
CH622771A5 (de)
EP0004494A1 (de) 1,3-Dihydro-3-(1-(2-(2,3-dihydro-1,4-benzodioxin-2-yl)2-hydroxy-äthyl)piperidin-4-yl)2H-indol-2-on Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zubereitungen
CH619935A5 (de)
EP0021924B1 (de) Indol-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende pharmazeutische Zusammensetzungen
FR2556721A1 (fr) Nouveaux derives de o-mercaptopropanamide d'o amino-acides, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
CH650515A5 (fr) Derives steroides 3-amines et leurs sels, procedes de preparation, ainsi que les medicaments et compositions les renfermant.
EP0214004B1 (de) Gegebenenfalls etherifizierte oder esterifizierte in Stellung 2 substituierte 4-OH-Chinolincarbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende Zubereitungen
EP0012072B1 (de) Von 2-Hydroxycyclopentancarbonsäure abgeleitete beta-Lactone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
EP0176444B1 (de) Verfahren zur Herstellung von 4H-1,2,4-Triazol-Derivaten, so erhaltene neue Triazole, ihre Verwendung als Arzneimittel und sie enthaltende pharmazeutische Zusammensetzungen
EP0105776B1 (de) C-Homo-9-oxaergolinderivate, ihre Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen
CA1200554A (fr) Procede de preparation de nouveaux derives de l'aminomethyl 14-indole-4-methanol et de leurs sels
EP0002156A1 (de) 7-Amino-5H-Benzocyclohepten-Derivate und ihre Salze, Verfahren zu deren Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Präparate
CA1096372A (fr) Procede de preparation de nouveaux 2,2-dimethyl 19- nor steroides
EP0210909B1 (de) Alkylaminoamide und ihre Salze, ihre Herstellung, ihre Verwendung als Arzneimittel und diese Verbindungen enthaltende Zusammensetzungen
CA1060020A (fr) Procede de preparation de nouveaux derives de la dibenzo/b,c/ thiepine et leurs sels
CA1115276A (fr) Procede de preparation de nouveaux derives de l'acide 2/(4-quinoleinyl) amino/ 5-fluorobenzoique
CA1105022A (fr) Procede de preparation de nouveaux derives de la benzophenone
CA1076583A (fr) Procede de preparation de nouveaux derives de n-hydroxy thiazole 5-carboxamide
CA1175415A (fr) Procede de preparation de nouveaux derives steroides 3-amino substitue
EP0034989B1 (de) Cycloheptindolol-Derivate und ihre Salze mit Säuren, ihre Herstellung, Verwendung als Heilmittel und Zusammensetzungen, die sie enthalten

Legal Events

Date Code Title Description
PL Patent ceased